1,687
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Detection of polyomavirus microRNA-5p expression in saliva shortly after kidney transplantation

, , ORCID Icon, , ORCID Icon, , , ORCID Icon & show all
Article: 1898838 | Received 07 Jan 2021, Accepted 02 Mar 2021, Published online: 12 Mar 2021

References

  • DeCaprio JA, Garcea RL. A cornucopia of human polyomaviruses. Nat Rev Microbiol. 2013;11(4):264–8.
  • Moens U, Krumbholz A, Ehlers B, et al. Biology, evolution, and medical importance of polyomaviruses: an update. Infect Genet Evol. 2017;54:18–38.
  • Calvignac-Spencer S, Feltkamp MC, Daugherty MD, et al., Polyomaviridae Study Group of the International Committee on Taxonomy of Viruses. A taxonomy update for the family Polyomaviridae. Arch Virol. 2016;161(6):1739–1750. .
  • Delbue S, Tremolada S, Branchetti E, et al. First identification and molecular characterization of lymphotropic polyomavirus in peripheral blood from patients with leukoencephalopathies. J Clin Microbiol. 2008;46(7):2461–2462.
  • Martini F, Corallini A, Balatti V, et al. Simian virus 40 in humans. Infect Agent Cancer. 2017;2(1):13.
  • Moens U, Van Ghelue M, Song X, et al. Serological cross-reactivity between human polyomaviruses. Rev Med Virol. 2013;23(4):250–264.
  • Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology. 2013;437(2):63–72.
  • Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyomavirus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67(1):103–109.
  • Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease undernew immunosuppressive drugs: a cause of renal graft dysfunctionand graft loss. Transplantation. 1999;67(6):918–922.
  • Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renaltransplant recipients. N Engl J Med. 2002;347(7):488–496.
  • Arthur RR, Shah KV, Baust SJ, et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrowtransplants. N Engl J Med. 1986;315(4):230–234.
  • Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bonemarrow transplantation. J Clin Oncol. 1995;13(5):1103–1109.
  • Hirsch HH. Polyoma and Papilloma Virus Infections After Hematopoietic Stem Cell or Solid Organ Transplantation. In: Bowden P, Ljungman P, Snydman DR, editors. Transplant infections. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 465–482.
  • Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008;41(1):11–18.
  • Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis. 2003;3(10):611–623.
  • Sharma SG, Nickeleit V, Herlitz LC, et al. BK polyoma virus nephropathy in the native kidney. Nephrol Dial Transplant. 2013;28:620–631.
  • Roy S, Mieczkowski PA, Weida C, et al. BK polyomavirus nephropathy with systemic viral spread: whole genome sequencing data from a fatal case of BKPyV infection. Transpl Infect Dis. 2020;22(2):e13269.
  • Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277–1286.
  • Pires EP, Bernardino-Vallinoto CV, Alves DM, et al. Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease, Transpl. Infect Dis. 2011;13:633–637.
  • Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323–330.
  • Kumar D. Emerging viruses in transplantation, Curr. Opin Infect Dis. 2010;23(4):374–378.
  • Singh HK, Reisner H, Derebail VK, et al. Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease. Transplantation. 2015;99(3):609–615.
  • Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol. 2009;20(2):416–427.
  • Robaina TF, Mendes GS, Benati FJ, et al. Shedding of polyomavirus in the saliva of immunocompetent individuals. J Med Virol. 2013;85(1):144–148.
  • Sarmento DJS, Palmieri M, Galvão GS, et al. BK virus salivary shedding and viremia in renal transplant recipients. J Appl Oral Sci. 2019;27:e20180435.
  • Jeffers LK, Madden V, Webster-Cyriaque J. BK virus has tropismfor human salivary gland cells in vitro: implications for transmission. Virology. 2009;394(2):183–193.
  • Figueiredo MA, DominguesFink MC, Castro T, et al. Detection of human polyomaviruses JC and BK in liver pre-transplant patients. Oral Dis. 2017;23(8):1127–1133.
  • Castro T, Fink MCD, Figueiredo M, et al. Polyomavirus BK and JC in individuals with chronic kidney failure, kidney transplantation, and healthy controls. J Clin Virol. 2017;89:5–9.
  • Bauman Y, Mandelboim O. MicroRNA based immunoevasion mechanism of human polyomaviruses. RNA Biol. 2011;8(4):591–594.
  • Lagatie O, Tritsmans L, Stuyver LJ. The miRNA world of polyomaviruses. Virol J. 2013;10(1):268–288.
  • Sullivan CS, Grundhoff A, Tevethia S, et al. Expression and function of microRNAs in viruses great and small. Cold Spring Harb Symp Quant Biol. 2006;71:351–356.
  • Lagatie O, Van Loy T, Tritsmans L, et al. Viral miRNAs in plasma and urine divulge JC polyomavirus infection. Virol J. 2014;2:11–158.
  • Pietilä T, Nummi M, Auvinen P, et al. Expression of BKV and JCV encoded microRNA in human cerebrospinal fluid, plasma and urine. J Clin Virol. 2015;65:1–5.
  • Rocca A, Martelli F, Delbue S, et al. The JCPyV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML. J Clin Virol. 2015;70:1–6.
  • Kim MH, Lee YH, Seo JW, et al. Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients. PLoS One. 2017;12(12):e0190068.
  • Giovannelli I, Martelli F, Repice A, et al. Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. J Neurovirol. 2015;21:666‐670.
  • Li JY, McNicholas K, Yong TY, et al. BK virus encoded microRNAs are present in blood of renal transplant recipients with BK viral nephropathy. Am J Transplant. 2014;14: 1183‐1190.
  • Martelli F, Mencarini J, Rocca A, et al. Polyomavirus microRNA in saliva reveals persistent infectious status in the oral cavity. Virus Res. 2018;249:1–7.
  • Broekema NM, Imperiale MJ. miRNA regulation of BK polyomavirus replication during early infection. Proc Natl Acad Sci U S A. 2013;110(20):8200–8205.
  • Martelli F, Wu Z, Delbue S, et al. BK polyomavirus microrna levels in exosomes are modulated by non-coding control region activity and down-regulate viral replication when delivered to non-infected cells prior to infection. Viruses. 2018;10(9):E466. . pii
  • Martelli F, Giannecchini S. Polyomavirus microRNAs circulating in biological fluids during viral persistence. Rev Med Virol. 2017;27(3):e1927.
  • Baez CF, Guimarães MA, Martins RA, et al. Detection of Merkel cell polyomavirus in oral samples of renal transplant recipients without Merkel cell carcinoma. J Med Virol. 2013;85(11):2016–2019.
  • Manitpisitkul W, Drachenberg C, Ramos E, et al. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation. 2009;88(1):83–88.
  • Kriesche HU. Treatment for BK virus: incidence, risk factors andoutcomes for kidney transplant recipients in the USA. Transpl Int. 2009;22(6):626–634.
  • Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK Replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: A prospective, randomized, multicenter study. Am J Transplant. 2013;13(1):136–145.
  • Huang Y, Zeng G, Randhawa PS. Detection of BKV encoded mature MicroRNAs in kidney transplant patients: clinical and biologic insights. J Clin Virol. 2019;119:6–10.
  • Virtanen E, Seppälä H, Helanterä I, et al. BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy. J Clin Virol. 2018;102:70–76.
  • Zeng G, Wang Z, Huang Y, et al. Cellular and viral miRNA expression in polyomavirus BK infection. Transpl Infect Dis. 2019;21(5):e13159.
  • Tian YC, Li YJ, Chen HC, et al. Polyomavirus BK-encoded microRNA suppresses autoregulation of viral replication. Biochem Biophys Res Commun. 2014;447:543–549.
  • Giannecchini S. Evidence of the mechanism by which polyomaviruses exploit the extracellular vesicle delivery system during infection. Viruses. 2020;12(6):585–591.
  • Shikova E, Emin D, Alexandrova D, et al. Detection of merkel cell polyomavirus in respiratory tract specimens. Intervirology. 2017;60(1–2):28–32.
  • Matos A, Duque V, Luxo C, et al. Individuals infected with JC polyomavirus do not present detectable JC virus DNA in oropharyngeal fluids. J Gen Virol. 2012;93:692–697.
  • Sundsfjord A, Spein AR, Lucht E, et al. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J ClinMicrobiol. 1994;32:1390–1394.
  • Loyo M, Guerrero-Preston R, Brait M, et al. High JC virus load in tongue carcinomas may be a risk factor for tongue tumorigenesis. Virchows Arch. 2008;452(4):405–410.
  • Zheng Y, Xia P, Zheng HC, et al. The screening of viral risk factors in tongue and pharyngolaryngeal squamous carcinoma. Anticancer Res. 2010;30(4):1233–1238.